Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 91.8 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | n/a | (0.01) | (2.80)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (3.96) | (2.40)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (0.96) | (0.30)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (1.76) | (0.50)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | n/a | (2.19) | (0.60)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Holding(s) in Company | 28-May-2025 | 07:00 | RNS |
£150,000 Convertible Loan Note Issue | 20-May-2025 | 07:00 | RNS |
Final results for the year ended 31 December 2024 | 30-Apr-2025 | 11:18 | RNS |
No recent information was found.
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.90p |
Change Today | -0.15p |
% Change | -7.32 % |
52 Week High | 2.30p |
52 Week Low | 1.40p |
Volume | 1,801,018 |
Shares Issued | 396.39m |
Market Cap | £7.53m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:13 | 25,000 @ 1.94p |
15:08 | 47,000 @ 1.94p |
14:44 | 5 @ 2.00p |
13:48 | 10,279 @ 1.94p |
13:26 | 187,477 @ 1.92p |
Finance Director | Nigel Ronald Lee |
You are here: research